Foucher, Christelle

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)

Ansquer, J.-C., Foucher, C., Rattier, S., Taskinen, M.-R., & Steiner, G. (2005) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 264

Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People

Ansquer, J.-C., Dalton, R. N., Caussé, E., Crimet, D., Le Malicot, K., & Foucher, C. (2008) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 107

Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study

Ansquer, J., Foucher, C., Aubonnet, P., & Le Malicot, K. (2009) · Current Pharmaceutical Design

Retinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

Cited by 72